Association of Hematological Parameters and Diabetic Neuropathy: A Retrospective Study

References

• Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights. 2016;11:S38440. doi:10.4137/BMI.S38440
   Google Scholar
• Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metabolic Syndrome Obesity. 2016;9:91. doi:10.2147/DMSO.S97563
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Gallagher G, Fridman V, Feldman EL. Diabetic neuropathy: what does the future hold? Diabetologia. 2020;63(5):891–897. doi:10.1007/s00125-020-05085-9
   PubMed Web of Science ®Google Scholar
• Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral neuropathy and all-cause and cardiovascular mortality in US adults: a prospective cohort study. Ann Int Med. 2021;174(2):167–174. doi:10.7326/M20-1340
   PubMed Web of Science ®Google Scholar
• Farooqui R, Afsar N, Afroze IA. Role and significance of hematological parameters in diabetes mellitus. Ann Pathol Lab Med. 2019;6(3):158–162. doi:10.21276/apalm.2355
   Google Scholar
• Liu S, Zheng H, Zhu X, et al. Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2017;130:90–97. doi:10.1016/j.diabres.2017.05.008
   PubMed Web of Science ®Google Scholar
• Cardoso CR, Leite NC, Salles GF. Importance of hematological parameters for micro-and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovascul Diabetol. 2021;20(1):1–13. doi:10.1186/s12933-020-01183-5
   PubMed Web of Science ®Google Scholar
• Ranjith K, Potu B, Anju M, Velladath SU, Hande M. Evaluation and comparison of blood parameters in diabetic patients with and without peripheral neuropathy. J Clin Diagn Res. 2018;12:7.
   Google Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Cana J Cardiol. 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005
   PubMed Web of Science ®Google Scholar
• Su J-B, Zhao L-H, Zhang X-L, et al. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovascul Diabetol. 2018;17(1):1–9. doi:10.1186/s12933-018-0693-0
   PubMedGoogle Scholar
• Al-Shehri FS. Glycemic control and microvascular complications of type 2 diabetes among Saudis. J Diabetes Mellit. 2019;9(4):167–175. doi:10.4236/jdm.2019.94016
   Google Scholar
• Bhutto AR, Abbasi A, Abro AH. Correlation of hemoglobin A1c with red cell width distribution and other parameters of red blood cells in type II diabetes mellitus. Cureus. 2019;11(8). doi:10.7759/cureus.5533
   PubMed Web of Science ®Google Scholar
• Jabeen F, Fawwad A, Rizvi HA, Alvi F. Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients. Pakistan J Med Sci. 2013;29(1):152. doi:10.12669/pjms.291.2592
   PubMed Web of Science ®Google Scholar
• Bhatta S, Singh S, Gautam S, Osti BP. Mean platelet volume and platelet count in patients with type 2 diabetes mellitus and impaired fasting glucose. J Nepal Health Res Counc. 2018;16(41):392–395. doi:10.33314/jnhrc.v16i41.1502
   Google Scholar
• Arkew M, Yemane T, Mengistu Y, Gemechu K, Tesfaye G, Johnson C. Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: a comparative cross-sectional study. PLoS One. 2021;16(6):e0253286. doi:10.1371/journal.pone.0253286
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Y, Wan Y, Fan Z, Xu R. The relationship between red blood cell distribution width and incident diabetes in Chinese adults: a cohort study. J Diabetes Res. 2020;2020:2. doi:10.1155/2020/1623247
   Web of Science ®Google Scholar
• Adnan M, Aasim M. Prevalence of type 2 diabetes mellitus in adult population of Pakistan: a meta-analysis of prospective cross-sectional surveys. Ann Glob Health. 2020;86(1). doi:10.5334/aogh.2679
   PubMed Web of Science ®Google Scholar
• Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgrad Med J. 2006;82(964):95–100. doi:10.1136/pgmj.2005.036137
   PubMed Web of Science ®Google Scholar
• Casadei G, Filippini M, Brognara L. Glycated hemoglobin (HbA1c) as a biomarker for diabetic foot peripheral neuropathy. Diseases. 2021;9(1):16. doi:10.3390/diseases9010016
   PubMed Web of Science ®Google Scholar
• Lai YR, Chiu WC, Huang CC, et al. HbA1C variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes. Front Neurosci. 2019;13:90. doi:10.3389/fnins.2019.00090
   PubMed Web of Science ®Google Scholar
• Nathan DM; DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16. doi:10.2337/dc13-2112
   PubMed Web of Science ®Google Scholar
• Christopher MM. Hematologic complications of diabetes mellitus. Veter Clin North Am. 1995;25(3):625–637. doi:10.1016/S0195-5616(95)50058-0
   Google Scholar
• Ansari P, Hannan J, Azam S, Jakaria M. Challenges in Diabetic Micro-Complication Management: focus on Diabetic Neuropathy. Int J Transl Med. 2021;1(3):175–186. doi:10.3390/ijtm1030013
   Google Scholar
• Chen M, Zhu Y, Wang J, Wang G, Wu Y. The predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio levels of diabetic peripheral neuropathy. J Pain Res. 2021;14:2049–2058. doi:10.2147/JPR.S304595
   PubMed Web of Science ®Google Scholar
• Suslova TE, Sitozhevskii AV, Ogurkova ON, et al. Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP-and NO-dependent mechanisms in the insulin-mediated platelet aggregation. Front Physiol. 2015;5:501. doi:10.3389/fphys.2014.00501
   PubMed Web of Science ®Google Scholar
• Yuri Gasparyan A, Ayvazyan L, Mikhailidis P, Kitas D. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58. doi:10.2174/138161211795049804
   PubMed Web of Science ®Google Scholar
• El Haouari M, Rosado JA. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. Blood Cells Mol Dis. 2008;41(1):119–123. doi:10.1016/j.bcmd.2008.02.010
   PubMed Web of Science ®Google Scholar
• Ozder A, Eker HH. Investigation of mean platelet volume in patients with type 2 diabetes mellitus and in subjects with impaired fasting glucose: a cost-effective tool in primary health care? Int J Clin Exp Med. 2014;7(8):2292.
   PubMed Web of Science ®Google Scholar
• Lippi G, Salvagno GL, Nouvenne A, Meschi T, Borghi L, Targher G. The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. Prim Care Diabete. 2015;9(3):226–230. doi:10.1016/j.pcd.2014.08.002
   PubMed Web of Science ®Google Scholar
• Akinsegun A, Olusola DA, Sarah J-O, et al. Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J. 2014;3:18.
   Google Scholar
• Xiao W, Huang Y, Dong J, Zhang X, Hu J. Relationship between platelet volume indices with macrovascular and peripheral neuropathy complications in type 2 diabetic patients. J Diabet. 2014;6(4):298–303. doi:10.1111/1753-0407.12104
   PubMed Web of Science ®Google Scholar
• Das A, Mukhopadhyay S. The evil axis of obesity, inflammation and type-2 diabetes. Endo Metabol Immu Disorder Drug Target. 2011;11(1):23–31. doi:10.2174/187153011794982086
   PubMedGoogle Scholar
• Agrawal NK, Kant S. Targeting inflammation in diabetes: newer therapeutic options. World J Diabete. 2014;5(5):697. doi:10.4239/wjd.v5.i5.697
   PubMedGoogle Scholar
• Bilgin S, Tel BMA, Kahveci G, et al. Hypothyroidism is strongly correlated with mean platelet volume and red cell distribution width. Nat J Health Sci. 2021;6(1):7–10.
   Google Scholar
• Duman TT, Aktas G, Atak B, Kocak MZ. Is mean platelet volume to platelet ratio a promising indicator of diabetic regulation in type 2 diabetes mellitus. J Med Res. 2018;4(3):137–139. doi:10.31254/jmr.2018.4306
   Google Scholar
• Bakirci EM, Demirtas L, Degirmenci H, et al. Relationship of the total atrial conduction time to subclinical atherosclerosis, inflammation and echocardiographic parameters in patients with type 2 diabetes mellitus. Clinics. 2015;70(2):73–80. doi:10.6061/clinics/2015(02)01
   PubMed Web of Science ®Google Scholar
• Onalan E, Gozel N, Donder E. Can hematological parameters in type 2 diabetes predict microvascular complication development? Pakistan J Med Sci. 2019;35(6):1511. doi:10.12669/pjms.35.6.1150
   PubMed Web of Science ®Google Scholar
• Abou Raya WM, Abd Elhamed SS, El Salanty NH. Relationship between neutrophil-to-lymphocyte ratio and diabetic neuropathy in type 2 diabetes mellitus. Scient J Al Azhar Med Facul Girls. 2020;4(2):217–224. doi:10.4103/sjamf.sjamf_26_20
   Google Scholar
• Atak BM, Kahveci GB, Bilgin S, Kurtkulagi O. Platelet to lymphocyte ratio in differentiation of benign and malignant thyroid nodules. Exper Biomed Res. 2021;4(2):148–153.
   Google Scholar
• Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli AMB. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Revista da Assoc Méd Brasil. 2019;65:38–42. doi:10.1590/1806-9282.65.1.38
   PubMed Web of Science ®Google Scholar
• Beyan C, Kaptan K, Beyan E, Turan M. The platelet count/mean corpuscular hemoglobin ratio distinguishes combined iron and vitamin B12 deficiency from uncomplicated iron deficiency. Int J Hematol. 2005;81(4):301–303. doi:10.1532/IJH97.E0311
   PubMed Web of Science ®Google Scholar